IP Library Patent Application 13548385
Patent Application
App. No. 13/548,385

Combined Space Maintenance and Bone Regeneration System for the Reconstruction of Large Osseous Defects

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/548,385
Abstract

Systems, methods and compositions useful for treatment of traumatic bone injuries are provided. In one embodiment, a bone reconstruction system comprising a space maintaining composition comprising porous polymethylmethacrylate; and an osseous generating construct comprising a polymethylmethacrylate chamber that comprises one or more osseous generating materials is provided. Associated compositions and methods are also provided.

Claims (26)

1 . A bone reconstruction system comprising:

a space maintaining composition comprising porous polymethylmethacrylate; and

an osseous generating construct comprising a polymethylmethacrylate chamber that comprises one or more osseous generating materials.

2 . The system of claim 1 wherein the osseous generating materials comprises one or more materials selected from the group consisting of morselized autologous bone, a demineralized bone matrix, a scaffold matrix comprising a bone generating compound, and a combination thereof.

3 . The system of claim 2 wherein the scaffold matrix comprises one or more materials selected from the group consisting of a synthetic polymer, a ceramic material, a metal material, and a combination thereof.

4 . The system of claim 1 wherein the osseous generating construct further comprises autologous cells.

5 . The system of claim 1 wherein the osseous generating construct further comprises recombinant human bone morphogenetic proteins.

6 . The system of claim 1 wherein the space maintaining composition further comprises an antibiotic.

7 . The system of claim 6 wherein the antibiotic is present in a microparticle comprising poly(lactic-co-glycolic acid).

8 . The system of claim 1 wherein the space maintaining composition further comprises a bioactive factor.

9 . The system of claim 8 wherein the bioactive factor is present in a microparticle comprising poly(lactic-co-glycolic acid).

10 . A space maintaining composition comprising porous polymethylmethacrylate, wherein the porosity of the space maintaining composition is from about 10% to about 50%.

11 . The space maintaining composition of claim 10 comprising pores having a diameter of from about 50 μm to about 150 μm.

12 . The space maintaining composition of claim 10 comprising interconnectivities less than about 60% for connection sizes of 50 μm or larger.

13 . The space maintaining composition of claim 10 further comprising an antibiotic.

14 . A method comprising:

placing a space maintaining composition comprising porous polymethylmethacrylate within an osseous defect; and

placing an osseous generating construct comprising polymethylmethacrylate proximate to the osseous defect so as to generate an osseous construct.

15 . The method of claim 14 further comprising removing the space maintaining composition from the osseous defect and placing the osseous construct within the osseous defect.

16 . The method of claim 14 wherein the space maintaining composition further comprises an antibiotic.

17 . A method of making a space maintaining composition comprising:

combining a methylmethacrylate monomer phase and an aqueous porogen phase comprising a hydrogel porogen; and

forming a porous polymethylmethacrylate.

18 . The method of claim 17 wherein the aqueous porogen phase is present in an amount of about 10 weight percent to about 50 weight percent.

19 . The method of claim 17 wherein the hydrogel porogen comprises one or more of carboxymethylcellulose, gelatin, collagen, pluronic, hyaluronic acid, alginate, chitosan, fibrin, agarose, poly(acrylic acid), poly(vinyl alcohol), poly(vinyl phosphonic acid), poly(glutamic acid), poly(ethylene glycol), poly(ethylene oxide), poly(phosphazene), oligo(poly(ethylene glycol) fumarate), poly(N-isopropyl acrylamide), or poly(hydroxyethyl methacrylate).

20 . The method of claim 17 wherein the hydrogel porogen is present in the aqueous porogen phase in an amount of about 7 weight percent to about 9 weight percent.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 3, 2013
From: RICE UNIVERSITY
To: US ARMY, SECRETARY OF THE ARMY
Reel/Frame 031753/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2013
From: MIKOS, ANTONIOS G.; WONG, MARK E.; YOUNG, SIMON W.; SHI, MENG; KASPER, F. KURTIS; SPICER, PATRICK; KRETLOW, JAMES D.
To: WILLIAM MARSH RICE UNIVERSITY
Reel/Frame 029587/0698 →